Although chronic myelogenous leukemia in pregnancy is rare, its management and treatment is more difficult and complicated.Treatment of patients with chronic myelogenous leukemia includes bone marrow transplantation, however in less than 30% of patients the donor’s organ would be accepted. To this end, cytotoxic therapy is considered as an alternative therapeutic option. This option provides sa...

although chronic myelogenous leukemia in pregnancy is rare, its management and treatment is more difficult and complicated. treatment of patients with chronic myelogenous leukemia includes bone marrow transplantation, however in less than 30% of patients the donor’s organ would be accepted. to this end, cytotoxic therapy is considered as an alternative therapeutic option. this option provides s...

background: solid tumors may occur in 3% of the patients with chronic myeloid leukemia (cml). in this paper, we presented a case of cml following treatment of colon cancer. case presentation: a 25 year old man was diagnosed of adenocarcinoma of rectosigmoid treated with fluorouracil-based chemotherapy. following relapse, he received florouracil, oxaliplatin and irinotecan during the next year. ...

purpose: to report a case of acute myelogenous leukemia (aml) presenting with periorbital cellulitis and progressing to facial and neck cellulitis. case report: a 17 year old male patient presented with periorbital cellulitis which progressed to the right hemifacial and neck area. he did not respond to regular antibiotic therapy. peripheral blood smear showed leukocytosis with predominance of i...

1. dept. of hematology, oncology, kermanshah university of medical sciences, kermanshah, iran 2. medical biology research center, kermanshah university of medical sciences, kermanshah, iran 3. students research committee, kermanshah university of medical sciences, kermanshah, iran     corresponding author: masoud sadeghi, msc; degree in biochemistry tel: (+91) 8338428221 email: sadeghi_mbrc@yah...

previous studies have demonstrated some significant differences in hla allele frequencies in leukemic patients and normal subjects. we have analyzed hla class ii alleles and haplotypes in 60 iranian patients with acute myelogenous leukemia (aml) and 180 unrelated normal subjects. blood samples were collected after obtaining informed consents. from the patients and control dna extraction and hla...

in chronic myelogenous leukemia (cml), the mature granulocytes originate from a stem cell line harboring an abnormal chromosome, therefore it is possible that metabolic-functional abnormalities occur in the morphologically mature cells. in the present study, the phagocytic activity including intracellular killing, nitro blue tetrazolium (nbt) reduction, and phagocytosis were studied in 37 cml p...

objective: one of the most significant damages to the genetic material is oxidative deamination of dna and free nucleotides in the cell pool. incorporation of deaminated purine nucleotides such as inosine triphosphate (itp, ditp) into the dna can increase the frequency of base substitution mutation. it has been suggested that presence and accumulation of these rough nucleotides can lead to gene...

a retrospective study was done on 130 aml patients treated in shariati and imam hospitals in tehran from 1991 to 1997 to investigate the value of three post-remission methods of treatment. all patients who were in complete remission (cr) (group i) had been treated with ara-c (300 mg/m2/day continuous infusion for 5 days) and daunorubicine (45 mg/m2/day for 3 days) as induction and early consoli...

introduction: imatinib, a tyrosine kinase inhibitor which resulted in much improvement in the treatment of chronic myelogenous leukemia (cml), may adversely affect thyroid gland function. to date, assessment of thyroid function during imatinib therapy has limited to retrospective studies. the aim of this study was to evaluate the effects of imatinib on thyroid function in a prospective manner. ...